➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Harvard Business School
Boehringer Ingelheim
Moodys
Express Scripts

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

OCTREOTIDE ACETATE (PRESERVATIVE FREE) Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Octreotide Acetate (preservative Free) patents expire, and what generic alternatives are available?

Octreotide Acetate (preservative Free) is a drug marketed by Fresenius Kabi Usa, Mylan Institutional, Sagent Pharms Inc, and West-ward Pharms Int. and is included in four NDAs.

The generic ingredient in OCTREOTIDE ACETATE (PRESERVATIVE FREE) is octreotide acetate. There are twenty drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the octreotide acetate profile page.

US ANDA Litigation and Generic Entry Outlook for Octreotide Acetate (preservative Free)

A generic version of OCTREOTIDE ACETATE (PRESERVATIVE FREE) was approved as octreotide acetate by WEST-WARD PHARMS INT on April 8th, 2005.

  Start Trial

Summary for OCTREOTIDE ACETATE (PRESERVATIVE FREE)
Drug patent expirations by year for OCTREOTIDE ACETATE (PRESERVATIVE FREE)
Pharmacology for OCTREOTIDE ACETATE (PRESERVATIVE FREE)

US Patents and Regulatory Information for OCTREOTIDE ACETATE (PRESERVATIVE FREE)

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa OCTREOTIDE ACETATE (PRESERVATIVE FREE) octreotide acetate INJECTABLE;INJECTION 077457-001 Feb 10, 2006 AP RX No No   Start Trial   Start Trial   Start Trial
Sagent Pharms Inc OCTREOTIDE ACETATE (PRESERVATIVE FREE) octreotide acetate INJECTABLE;INJECTION 090834-001 Nov 12, 2013 AP RX No No   Start Trial   Start Trial   Start Trial
Mylan Institutional OCTREOTIDE ACETATE (PRESERVATIVE FREE) octreotide acetate INJECTABLE;INJECTION 079198-001 Feb 10, 2011 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
Merck
Dow
McKinsey
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.